Bioanalytical Strategy: Authorities’ expectations to consider

November 2018. Article “Bioanalytical Strategy: Authorities’ expectations to consider” published from VelaLabs’ CEO, Dr. Markus Fido

In the November 2018 issue of Cleanroom Technology the leadership of VelaLabs in the field of bioanalytical characterisation of biopharmaceuticals was demonstrated by an article of Dr. Markus Fido


VelaLabs supports its clients and partners with knowledge and experience on authorities’ expectations towards analytical methods applied for characterization and  market release of biopharmaceuticals. In collaboration with regulatory agencies in Austria, VelaLabs CEO, Dr. Markus Fido, published an article on this particular topic.

Link to the article